← Open Payments lookup

SYDNEY JOHNSTON: Open Payments

NPI 1619502341 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,330 in 47 payments from 13 companies in 2025. Trend: 2023 $433 · 2024 $1,014 · 2025 $1,330

Food & beverage: $1,258Education: $72
CompanyPaymentsAmount
GENZYME CORPORATION30$824
AstraZeneca Pharmaceuticals LP3$203
SANOFI-AVENTIS U.S. LLC1$72
Lilly USA, LLC3$56
Amgen Inc.2$34
Regeneron Healthcare Solutions, Inc.1$24
Takeda Pharmaceuticals U.S.A., Inc.1$20
PFIZER INC.1$19
Novartis Pharmaceuticals Corporation1$19
Arcutis Biotherapeutics, Inc.1$16

Products named: DUPIXENT, FASENRA, AYVAKIT, EBGLYSS, TEZSPIRE, EOHILIA, CIBINQO, Rhapsido.

Industry payments across NE — which companies pay providers there.